Details for Patent: 8,318,201
✉ Email this page to a colleague
Which drugs does patent 8,318,201 protect, and when does it expire?
Patent 8,318,201 protects NOURIANZ and is included in one NDA.
This patent has thirteen patent family members in ten countries.
Summary for Patent: 8,318,201
| Title: | Method of stabilizing diarylvinylene compound |
| Abstract: | ##STR00001## (wherein Y.sup.1 and Y.sup.2 may be the same or different and each represents a hydrogen atom, halogen or lower alkyl; and Z and A may be the same or different and each represents substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl) The present invention provides, for example, a method for stabilization of a diarylvinylene compound such as a compound represented by the above formula (I) or the like, or a pharmaceutically acceptable salt thereof in a solid formulation containing the diarylvinylene compound or the pharmaceutically acceptable salt thereof, which comprises allowing an inorganic substance and/or a colorant to exist in the solid formulation, and the like. |
| Inventor(s): | Uchida; Akihiro (Sunto-gun, JP), Ishikawa; Yasuhiro (Sunto-gun, JP), Ueno; Yasuhiko (Mishima, JP), Kaji; Kiichiro (Machida, JP), Aimoto; Masaharu (Sunto-gun, JP), Kaneko; Naoki (Sunto-gun, JP) |
| Assignee: | Kyowa Hakko Kirin Co., Ltd. (Tokyo, JP) |
| Application Number: | 10/528,451 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 8,318,201
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-001 | Aug 27, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-002 | Aug 27, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,318,201
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2003-336944 | Sep 29, 2003 |
| PCT Information | |||
| PCT Filed | September 29, 2004 | PCT Application Number: | PCT/JP2004/014687 |
| PCT Publication Date: | April 07, 2005 | PCT Publication Number: | WO2005/030219 |
International Family Members for US Patent 8,318,201
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 046169 | ⤷ Try a Trial | |||
| Australia | 2004275646 | ⤷ Try a Trial | |||
| Canada | 2540109 | ⤷ Try a Trial | |||
| China | 1845742 | ⤷ Try a Trial | |||
| European Patent Office | 1676578 | ⤷ Try a Trial | |||
| Spain | 2534220 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
